Bath & Body Works (NYSE:BBWI – Get Free Report) and Kingfisher (OTCMKTS:KGFHY – Get Free Report) are both mid-cap retail/wholesale companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation.
Earnings and Valuation
This table compares Bath & Body Works and Kingfisher”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Bath & Body Works | $7.31 billion | 0.87 | $798.00 million | $3.75 | 8.01 |
Kingfisher | $16.34 billion | 0.38 | $235.86 million | N/A | N/A |
Profitability
This table compares Bath & Body Works and Kingfisher’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Bath & Body Works | 11.10% | -47.44% | 15.18% |
Kingfisher | N/A | N/A | N/A |
Institutional & Insider Ownership
95.1% of Bath & Body Works shares are held by institutional investors. Comparatively, 0.0% of Kingfisher shares are held by institutional investors. 0.3% of Bath & Body Works shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Dividends
Bath & Body Works pays an annual dividend of $0.80 per share and has a dividend yield of 2.7%. Kingfisher pays an annual dividend of $0.43 per share and has a dividend yield of 6.1%. Bath & Body Works pays out 21.3% of its earnings in the form of a dividend.
Analyst Recommendations
This is a summary of current recommendations and price targets for Bath & Body Works and Kingfisher, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Bath & Body Works | 0 | 4 | 14 | 0 | 2.78 |
Kingfisher | 2 | 2 | 1 | 0 | 1.80 |
Bath & Body Works currently has a consensus price target of $42.19, indicating a potential upside of 40.39%. Given Bath & Body Works’ stronger consensus rating and higher possible upside, research analysts clearly believe Bath & Body Works is more favorable than Kingfisher.
Volatility & Risk
Bath & Body Works has a beta of 1.72, suggesting that its share price is 72% more volatile than the S&P 500. Comparatively, Kingfisher has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500.
Summary
Bath & Body Works beats Kingfisher on 10 of the 14 factors compared between the two stocks.
About Bath & Body Works
Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.
About Kingfisher
Kingfisher plc, together with its subsidiaries, supplies home improvement products and services primarily in the United Kingdom, Ireland, France, and internationally. It also operates retail stores under the B&Q, Castorama, Brico Dépôt, Screwfix, TradePoint, and Koçtas brands. The company sells its products through stores and e-commerce channels. Kingfisher plc was incorporated in 1982 and is headquartered in London, the United Kingdom.
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.